Ultra-Broadband Micromechanical Ultrasound (UMUS) as a Strategy to Correct Cyclophosphamide-Induced Myelosuppression Without Limiting Antitumor Efficacy
Cellular Physiology and Biochemistry · 24.04.2026 · 60 (2) · 199-212
DOI: 10.33594/000000862 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cellular Physiology and Biochemistry, online erschienen am 24.04.2026. Verfasst von Galina Solyanik und 6 weiteren Autor:innen. Beteiligte Einrichtung: RE Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology, National Academy of Sciences of Ukraine, 45, Vasylkivska str, Kyiv 03022,…. Hauptthemen laut MEDLINE: Cyclophosphamide, Carcinoma, Ehrlich Tumor, Bone Marrow, Antineoplastic Agents, Alkylating. Gefördert von: University of Lodz.
Abstract (Originalsprache)
Background/Aims: This study aimed to apply ultra-broadband micromechanical ultrasound (UMUS) for correction of myelosuppression caused by the cytotoxic effects of cyclophosphamide without limiting its antitumor efficacy.
Methods
The study included animals bearing transplanted Ehrlich carcinoma. Cyclophosphamide (CP) was administered once daily for three consecutive days starting on day 8 of tumor growth at a cumulative dose of 330 mg/kg per mouse. After completion of CP administration, a subset of animals was exposed to UMUS irradiation once daily for five days. Control groups included mice without tumors and tumor-bearing mice not exposed to CP or UMUS. Tumor growth kinetics were analyzed, and quantitative parameters of peripheral blood, bone marrow, and spleen were determined.
Results
The obtained data indicate that UMUS exposure does not reduce the antitumor efficacy of CP but is associated with enhanced recovery of the hematopoietic system the antitumor efficacy of CP but exerts a positive effect on the recovery of the hematopoietic system in the bone marrow. This is confirmed by a statistically significant increase in the number of cells (compared with animals not exposed to UMUS) in specific bone marrow hematopoietic pools, including myelokaryocytes, blast cells, erythroid, lymphoid, and megakaryocytic cells.
Conclusion
UMUS exposure was associated with accelerated recovery of multiple hematopoietic lineages in the bone marrow following cyclophosphamide-induced injury, without compromising antitumor efficacy. These findings suggest that UMUS may represent a promising non-pharmacological strategy to support hematopoietic regeneration during cytotoxic chemotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- RE Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology, National Academy of Sciences of Ukraine, 45, Vasylkivska str, Kyiv 03022, Ukraine.
- Evolus Technologies, Haifa 3551334, Israel.
Förderung
- University of Lodz
Zitieren
APA
Solyanik, G., Rodionova, N., Stepanov, Y. V., Kolesnik, D., Yakshibaeva, Y., Kuzmenko, A., & Volokh, K. (2026). Ultra-Broadband Micromechanical Ultrasound (UMUS) as a Strategy to Correct Cyclophosphamide-Induced Myelosuppression Without Limiting Antitumor Efficacy. Cellular Physiology and Biochemistry, 60(2), 199-212. https://doi.org/10.33594/000000862
Vancouver
Solyanik G, Rodionova N, Stepanov YV, Kolesnik D, Yakshibaeva Y, Kuzmenko A, et al. Ultra-Broadband Micromechanical Ultrasound (UMUS) as a Strategy to Correct Cyclophosphamide-Induced Myelosuppression Without Limiting Antitumor Efficacy. Cellular Physiology and Biochemistry. 2026;60(2):199-212. doi:10.33594/000000862
BibTeX
@article{Solyanik2026,
author = {Solyanik, Galina and Rodionova, Nataliya and Stepanov, Yurii V and Kolesnik, Denis and Yakshibaeva, Yulia and Kuzmenko, Alexandr and Volokh, Karl},
title = {Ultra-Broadband Micromechanical Ultrasound (UMUS) as a Strategy to Correct Cyclophosphamide-Induced Myelosuppression Without Limiting Antitumor Efficacy},
journal = {Cellular Physiology and Biochemistry},
year = {2026},
volume = {60},
number = {2},
pages = {199--212},
doi = {10.33594/000000862}
}
EUVIMED